XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Asset Purchase Agreement
High Trail
Common Stock
Common Stock
Asset Purchase Agreement
Common Stock
High Trail
Common Stock
June 30, 2020
Common Stock
March 12, 2020
Additional Paid-in Capital
Additional Paid-in Capital
Asset Purchase Agreement
Additional Paid-in Capital
High Trail
Accumulated Deficit
Accumulated Other Comprehensive Income/(Loss)
Beginning balance at Dec. 31, 2019 $ 10,727     $ 2         $ 140,477     $ (129,809) $ 57
Beginning balance, shares at Dec. 31, 2019       17,736,649                  
Net loss (17,967)                     (17,967)  
Forfeiture of restricted common stock, shares       (134,366)     (134,366) (371,329)          
Issuance of restricted common stock, shares       134,364     134,364 439,145          
Shares of restricted common stock retired in connection with vesting (139)               (139)        
Shares of restricted common stock retired in connection with vesting, shares       41,299                  
Stock-based compensation expense 12,610               12,610        
Other comprehensive loss (9)                       (9)
Ending balance at Jun. 30, 2020 5,222     $ 2         152,948     (147,776) 48
Ending balance, shares at Jun. 30, 2020       17,763,164                  
Beginning balance at Mar. 31, 2020 2,995     $ 2         147,777     (144,839) 55
Beginning balance, shares at Mar. 31, 2020       17,763,994                  
Net loss (2,937)                     (2,937)  
Forfeiture of restricted common stock, shares       (134,366)     (134,366)            
Issuance of restricted common stock, shares       134,364     134,364            
Shares of restricted common stock retired in connection with vesting, shares       828                  
Stock-based compensation expense 5,171               5,171        
Other comprehensive loss (7)                       (7)
Ending balance at Jun. 30, 2020 5,222     $ 2         152,948     (147,776) 48
Ending balance, shares at Jun. 30, 2020       17,763,164                  
Beginning balance at Dec. 31, 2020 23,382     $ 3         216,305     (192,935) 9
Beginning balance, shares at Dec. 31, 2020       27,074,791                  
Net loss (118,859)                     (118,859)  
Issuance of common stock upon exercise of stock option grants $ 8,749               8,749        
Issuance of common stock upon exercise of stock option grants, shares 978,495     978,495                  
Issuance of common stock related to exercise of warrants $ 40,284               40,284        
Issuance of common stock related to exercise of warrants, shares       1,047,140                  
Issuance of common stock in connection with acquisition of Healing Solution assets 39,454               39,454        
Issuance of common stock in connection with acquisition of Healing Solutions assets, shares       1,387,759                  
Issuance of restricted stock awards 3,370               3,370        
Issuance of restricted stock awards, shares       108,696                  
Issuance of warrants to High Trail 39,016               39,016        
Issuance of common stock 36,735 $ 11,075 $ 4,056           36,735 $ 11,075 $ 4,056    
Issuance of common stock, shares       2,666,667 704,548 130,000              
Reclassification of warrants to equity 80,022               80,022        
Forfeiture of restricted common stock, shares       (258,971)                  
Issuance of restricted common stock, shares       1,895,642                  
Stock-based compensation expense 8,539               8,539        
Other comprehensive loss (46)                       (46)
Ending balance at Jun. 30, 2021 175,777     $ 3         487,605     (311,794) (37)
Ending balance, shares at Jun. 30, 2021       35,734,767                  
Beginning balance at Mar. 31, 2021 38,465     $ 3         313,911     (275,488) 39
Beginning balance, shares at Mar. 31, 2021       30,590,796                  
Net loss (36,306)                     (36,306)  
Issuance of common stock related to exercise of warrants 112               112        
Issuance of common stock related to exercise of warrants, shares       7,180                  
Issuance of warrants to High Trail 39,016               39,016        
Issuance of common stock 36,735 $ 11,075 $ 4,056           36,735 $ 11,075 $ 4,056    
Issuance of common stock, shares       2,666,667 704,548 130,000              
Reclassification of warrants to equity 80,022               80,022        
Forfeiture of restricted common stock, shares       (258,971)                  
Issuance of restricted common stock, shares       1,895,642                  
Cancellation of RSU issued to consultant (57)               (57)        
Cancellation of RSU issued to consultant, shares       (1,095)                  
Stock-based compensation expense 2,735               2,735        
Other comprehensive loss (76)                       (76)
Ending balance at Jun. 30, 2021 $ 175,777     $ 3         $ 487,605     $ (311,794) $ (37)
Ending balance, shares at Jun. 30, 2021       35,734,767